X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (758) 758
Publication (40) 40
Newsletter (20) 20
Book Review (8) 8
Magazine Article (4) 4
Book Chapter (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (464) 464
mebendazole (420) 420
mebendazole - pharmacology (289) 289
humans (251) 251
female (201) 201
male (197) 197
mebendazole - therapeutic use (192) 192
index medicus (185) 185
pharmacology & pharmacy (185) 185
albendazole (171) 171
parasitology (150) 150
anthelmintics - pharmacology (133) 133
mice (130) 130
benzimidazoles - pharmacology (104) 104
mebendazole - analogs & derivatives (102) 102
albendazole - pharmacology (75) 75
adult (72) 72
anthelmintics - therapeutic use (72) 72
chemotherapy (72) 72
mebendazole - administration & dosage (68) 68
rats (66) 66
antinematodal agents - pharmacology (65) 65
echinococcosis - drug therapy (61) 61
benzimidazoles - therapeutic use (60) 60
drugs (60) 60
efficacy (58) 58
albendazole - therapeutic use (57) 57
tropical medicine (57) 57
child (56) 56
analysis (53) 53
benzimidazoles (52) 52
anthelmintics (51) 51
drug resistance (51) 51
cancer (50) 50
pharmacokinetics (49) 49
in-vitro (48) 48
sheep (48) 48
mebendazole - metabolism (47) 47
infections (46) 46
mebendazole - chemistry (46) 46
adolescent (45) 45
middle aged (44) 44
parasitic diseases (44) 44
dose-response relationship, drug (43) 43
research (42) 42
benzimidazole (41) 41
antinematodal agents - therapeutic use (40) 40
solubility (40) 40
mebendazole - pharmacokinetics (39) 39
research article (39) 39
tubulin (38) 38
drug therapy (37) 37
flubendazole (37) 37
microbiology (37) 37
praziquantel (37) 37
ivermectin (36) 36
thiabendazole - pharmacology (36) 36
veterinary sciences (35) 35
administration, oral (34) 34
echinococcosis (34) 34
treatment outcome (34) 34
chemistry, medicinal (33) 33
feces - parasitology (31) 31
larva - drug effects (31) 31
echinococcus - drug effects (30) 30
anthelmintics - administration & dosage (29) 29
immunology (29) 29
resistance (29) 29
haemonchus-contortus (28) 28
parasite egg count (28) 28
parasites (28) 28
oncology (27) 27
time factors (27) 27
tubulin - metabolism (27) 27
albendazole - administration & dosage (26) 26
drug therapy, combination (26) 26
hydatid-disease (26) 26
praziquantel - pharmacology (26) 26
mebendazole - blood (25) 25
microscopy, electron, scanning (25) 25
nematodes (25) 25
pharmacology (25) 25
albendazole - pharmacokinetics (24) 24
benzimidazole anthelmintics (24) 24
biochemistry & molecular biology (24) 24
cell line, tumor (24) 24
disease models, animal (24) 24
health aspects (24) 24
infectious diseases (24) 24
thiabendazole (24) 24
apoptosis (23) 23
benzimidazoles - metabolism (23) 23
bioavailability (23) 23
child, preschool (23) 23
dosage and administration (23) 23
echinococcosis, hepatic - drug therapy (23) 23
helminthiasis - drug therapy (23) 23
invitro (23) 23
microscopy, electron (23) 23
public, environmental & occupational health (23) 23
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (731) 731
Chinese (12) 12
French (10) 10
Spanish (7) 7
German (6) 6
Russian (5) 5
Portuguese (4) 4
Czech (3) 3
Japanese (3) 3
Bulgarian (1) 1
Korean (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC research notes, ISSN 1756-0500, 04/2019, Volume 12, Issue 1, pp. 234 - 7
We recently showed that the anti-helminthic compound mebendazole (MBZ) has immunomodulating activity by inducing a M2 to M1 phenotype switch in... 
Antigens, CD - immunology | Tetradecanoylphorbol Acetate - pharmacology | Humans | Antigens, CD - genetics | Protein-Tyrosine Kinases - immunology | Mebendazole - pharmacology | Interleukins - genetics | Protein-Tyrosine Kinases - genetics | Interleukins - immunology | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Antinematodal Agents - metabolism | Interferon-gamma - genetics | Phosphorylation - drug effects | Antinematodal Agents - pharmacology | Proto-Oncogene Proteins c-abl - immunology | Antigens, Differentiation, Myelomonocytic - immunology | Macrophages - immunology | Proto-Oncogene Proteins c-abl - genetics | Signal Transduction | Mebendazole - metabolism | Gene Expression Regulation | Protein-Serine-Threonine Kinases - genetics | THP-1 Cells | Macrophages - cytology | Pyrimidines - pharmacology | Receptors, Cell Surface - immunology | Antigens, Differentiation, Myelomonocytic - genetics | Heterocyclic Compounds, 2-Ring - pharmacology | Cell Differentiation - drug effects | Interferon-gamma - immunology | Lipopolysaccharides - pharmacology | Protein Binding | Macrophages - drug effects | Protein-Serine-Threonine Kinases - immunology | Protein Kinase Inhibitors - pharmacology | Interferon-gamma - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | Receptors, Cell Surface - genetics | Mebendazole | Tyrosine | Cytokines | Macrophages | Protein kinases | Cell culture | Phosphorylation | Phenotypes | Statistical analysis | Immune response | Dendritic cells | Extracellular signal-regulated kinase | CD80 antigen | Inflammation | Kinases | Lipopolysaccharides | CD163 antigen | Proteins | Monocytes | Immunotherapy | γ-Interferon | Cell cycle | Software | Cancer | DYRK1B | M1 polarisation | Monocytes and macrophages
Journal Article
Journal Article
Bulletin of the World Health Organization, ISSN 0042-9686, 2003, Volume 81, Issue 5, pp. 343 - 352
Objective To evaluate the efficacy of and resistance to mebendazole (500 mg) and levamisole (40 or 80 mg), alone or in combination, for the treatment of... 
Ascariasis/drug therapy | Mebendazole/pharmacology/administration and dosage | Trichuris/drug effects | Ascaris lumbricoides/drug effects | Trichuriasis/drug therapy | Levamisole/pharmacology/administration and dosage | Placebos | comparative study | WORM CONTROL | TRICHURIS-TRICHIURA | SOUTHERN REGION | randomized controlled trials | ascaris lumbricoides/drug effects | placebos | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ASCARIS-LUMBRICOIDES | trichuris/drug effects | ancylostoma/drug effects | SOIL-TRANSMITTED NEMATODES | DEWORMING PROGRAM | combination | ANTHELMINTIC RESISTANCE | United Republic of Tanzania (source : MeSH, NLM) | drug therapy | PEMBA-ISLAND | Necator americanus/drug effects | ANCYLOSTOMA-DUODENALE | treatment outcome | trichuriasis/drug therapy | levamisole/pharmacology/admihistration and dosage | mebendazole/pharmacology/administration and dosage | drug resistance | ascariasis/drug therapy | HUMAN HOOKWORM INFECTIONS | Tanzania - epidemiology | Levamisole - administration & dosage | Parasite Egg Count | Humans | Intestinal Diseases, Parasitic - drug therapy | Treatment Outcome | Nematode Infections - drug therapy | Levamisole - pharmacology | Mebendazole - pharmacology | Levamisole - therapeutic use | Antinematodal Agents - administration & dosage | Nematode Infections - parasitology | Mebendazole - therapeutic use | Antinematodal Agents - therapeutic use | Mebendazole - administration & dosage | Intestinal Diseases, Parasitic - parasitology | Antinematodal Agents - pharmacology | Drug Therapy, Combination | Child | Drug Resistance | Mebendazole | Evaluation | Dosage and administration | Drug therapy | Helminthiasis | Levamisole
Journal Article
Blood, ISSN 0006-4971, 06/2010, Volume 115, Issue 23, pp. 4824 - 4833
Journal Article
Journal Article
Investigational New Drugs, ISSN 0167-6997, 4/2018, Volume 36, Issue 2, pp. 323 - 331
Journal Article
Journal Article
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 04/2018, Volume 12, Issue 4, p. e0006422
Journal Article